Terms: = Colorectal cancer AND LDH AND Prognosis
54 results:
1. The Chemokine CXCL7 is Correlated with ldh-A and Predicts the prognosis of Patients with colorectal cancer.
Liang H; Li L; Huang B; Cheng G; Ao J; Hao S
Front Biosci (Landmark Ed); 2024 Apr; 29(4):166. PubMed ID: 38682188
[TBL] [Abstract] [Full Text] [Related]
2. NR4A1 depletion inhibits colorectal cancer progression by promoting necroptosis via the RIG-I-like receptor pathway.
Zhu J; Li J; Yang K; Chen Y; Wang J; He Y; Shen K; Wang K; Shi T; Chen W
Cancer Lett; 2024 Mar; 585():216693. PubMed ID: 38301909
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma.
Cao K; Zhu J; Lu M; Zhang J; Yang Y; Ling X; Zhang L; Qi C; Wei S; Zhang Y; Ma J
EBioMedicine; 2024 Jan; 99():104920. PubMed ID: 38101299
[TBL] [Abstract] [Full Text] [Related]
4. Evaluating Prognostic Value of Dynamics of Circulating Lactate Dehydrogenase in colorectal cancer Using Modeling and Machine Learning.
Ding H; Yuan M; Yang Y; Gupta M; Xu XS
Clin Pharmacol Ther; 2024 Apr; 115(4):805-814. PubMed ID: 37724436
[TBL] [Abstract] [Full Text] [Related]
5. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
[TBL] [Abstract] [Full Text] [Related]
6. The colon inflammatory index score can predict the survival outcome after resection of colorectal cancer: a retrospective multicentre study.
Akiyama T; Miyamoto Y; Matsuda A; Tokunaga R; Ogawa K; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Sonoda H; Yamada T; Yoshida H; Baba H
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7887-7894. PubMed ID: 37058251
[TBL] [Abstract] [Full Text] [Related]
7. Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial.
Salfati D; Huot M; Aparicio T; Lepage C; Taieb J; Bouché O; Boige V; Phelip JM; Dahan L; Bennouna J; Le Malicot K; Boussari O; Gornet JM
Dig Liver Dis; 2023 Jun; 55(6):791-798. PubMed ID: 36725401
[TBL] [Abstract] [Full Text] [Related]
8. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic cancer: A Propensity Score Matching Analysis.
Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
[TBL] [Abstract] [Full Text] [Related]
9.
Wijler LA; Dijk FJ; Quirindongo H; Raats DAE; Dorresteijn B; Furber MJW; May AM; Kranenburg O; van Dijk M
Oncotarget; 2022 Oct; 13():1094-1108. PubMed ID: 36242541
[TBL] [Abstract] [Full Text] [Related]
10. The Significance of the preoperative lactate dehydrogenase/albumin Ratio in the prognosis of Colon cancer: a retrospective study.
Xie Z; Zhou H; Wang L; Wu Y
PeerJ; 2022; 10():e13091. PubMed ID: 35295561
[TBL] [Abstract] [Full Text] [Related]
11. Changes in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection.
Chen J; Chen Q; Yao J; Jiang Y; Zhou J; Zhao H; Cai J
Ann Palliat Med; 2021 Oct; 10(10):10276-10292. PubMed ID: 34551571
[TBL] [Abstract] [Full Text] [Related]
12. Nomograms predicting primary lymph node metastases and prognosis for synchronous colorectal liver metastasis with simultaneous resection of colorectal cancer and liver metastases.
Yao J; Chen Q; Deng Y; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Zhao H; Cai J
Ann Palliat Med; 2021 Apr; 10(4):4220-4231. PubMed ID: 33832313
[TBL] [Abstract] [Full Text] [Related]
13. Contrast-Enhanced CT-based Textural Parameters as Potential Prognostic Factors of Survival for colorectal cancer Patients Receiving Targeted Therapy.
Zhao Y; Yang J; Luo M; Yang Y; Guo X; Zhang T; Hao J; Yao Y; Ma X
Mol Imaging Biol; 2021 Jun; 23(3):427-435. PubMed ID: 33108800
[TBL] [Abstract] [Full Text] [Related]
14. R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma.
Zhao F; Qin Y; Yang J; Liu P; He X; Zhou L; Zhou S; Gui L; Zhang H; Wang X; Jiang S; Zhong Q; Zhou Y; Shi Y
Asia Pac J Clin Oncol; 2020 Dec; 16(6):385-391. PubMed ID: 32779387
[TBL] [Abstract] [Full Text] [Related]
15. Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: a novel approach to screen for synergism.
Ruhnau J; Parczyk J; Danker K; Eickholt B; Klein A
BMC Cancer; 2020 Jul; 20(1):617. PubMed ID: 32615946
[TBL] [Abstract] [Full Text] [Related]
16. The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer.
Lisanti C; Basile D; Parnofiello A; Bertoli E; Andreotti VJ; Garattini SK; Bartoletti M; Cattaneo M; Di Nardo P; Bonotto M; Casagrande M; Da Ros L; Cinausero M; Foltran L; Pella N; Buonadonna A; Aprile G; Fasola G; Puglisi F
J Geriatr Oncol; 2020 Nov; 11(8):1268-1273. PubMed ID: 32576519
[TBL] [Abstract] [Full Text] [Related]
17. The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic colorectal cancer.
Basile D; Garattini SK; Corvaja C; Montico M; Cortiula F; Pelizzari G; Gerratana L; Audisio M; Lisanti C; Fanotto V; Ongaro E; Iacono D; Cardellino GG; Foltran L; Pella N; Buonadonna A; Aprile G; Di Maio M; Fasola G; Puglisi F
Oncologist; 2020 Aug; 25(8):661-668. PubMed ID: 32202020
[TBL] [Abstract] [Full Text] [Related]
18. What can preoperative blood tests tell us about colorectal cancer?
Kostakis ID; Vaiopoulos AG; Garoufalia Z; Papavassiliou AG; Kykalos S; Kouraklis G; Tsourouflis G
J BUON; 2018 Dec; 23(7):84-95. PubMed ID: 30722116
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic Significance of Serum Lactic Acid, Lactate Dehydrogenase, and Albumin Levels in Patients with Metastatic colorectal cancer.
Wei Y; Xu H; Dai J; Peng J; Wang W; Xia L; Zhou F
Biomed Res Int; 2018; 2018():1804086. PubMed ID: 30627541
[TBL] [Abstract] [Full Text] [Related]
20. The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer.
Roseweir AK; Clark J; McSorley ST; vanWyk HC; Quinn JA; Horgan PG; McMillan DC; Park JH; Edwards J
Int J Cancer; 2019 May; 144(9):2320-2329. PubMed ID: 30521130
[TBL] [Abstract] [Full Text] [Related]
[Next]
